History
Cancer Cell Journal is a peer-reviewed open-access journal published by Cell Press that covers cancer research. According to its
[about page](https://www.cell.com/cancer-cell/aims), “Cancer Cell provides a high-profile forum to promote major advances in cancer research and oncology. “
Cell Press, based in Cambridge, Massachusetts, publishes over
[50 scientific journals](https://www.cell.com/). Cell Press Journals are 50% open-access as of 2022. [Read our profile on the United States media and government.](https://mediabiasfactcheck.com/united-states-media-profile/)
Funded by / Ownership
The Cancer Cell Journal is published by Cell Press which is a subsidiary of
[Elsevier](https://en.wikipedia.org/wiki/Elsevier), a Dutch information and analytics company and one of the world’s foremost providers of scientific, technical, and medical information. It was established in 1880 as a publishing company. Elsevier’s parent company is RELX plc, a British multinational information and analytics company headquartered in London, England. The journal generates revenue through subscription fees and fees for open-access publishing.
Analysis / Bias
Cancer Cell Journal is a hybrid (some open-access) journal that publishes information and research related to cancer research. The journal primarily publishes research such as this
[CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance.](https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00007-7)
Cell Press is an open-access/hybrid publisher of scientific journals. There are two types of Open Access Journals, legitimate and predatory, both of which charge the author for publication.
[Predatory journals](https://predatoryjournals.com/about/) often lack peer review and are generally considered not credible. The Cancer Cell Journal is considered a [legitimate, open-access publisher](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017830/) that is frequently indexed in [PubMed](https://mediabiasfactcheck.com/pubmed/). However, Cell Press has been criticized for [retracting some studies.](https://retractionwatch.com/category/by-journal/cell/)
Although Cell Press has retracted some studies in other publications, Cancer Cell Journal publishes credible scientific studies that are factual and appropriately peer-reviewed.
Failed Fact Checks
- None in the Last 5 years